Paid Clinical Trials and Focus Groups by Category |
|
|
|
Conditions: Hyperglycemia; Critical Illness
Intervention:
Sponsors: Hospital Universitari Son Dureta; Fundació Mateu Orfila
Recruiting - verified March 2010
Condition: Prostate Cancer
Interventions: Drug: Testosterone; Drug: Etoposide
Sponsor: Sidney Kimmel Comprehensive Cancer Center
Recruiting - verified March 2010
Condition: Female Breast Cancer
Intervention: Drug: Estradiol
Sponsor: University of Wisconsin, Madison
Recruiting - verified March 2010
Condition: Hypogonadism
Intervention: Drug: r-hLH
Sponsor: Merck KGaA
Completed - verified March 2010
Condition: Prostate Cancer
Interventions: Drug: temsirolimus; Biological: bevacizumab; Genetic: polymorphism analysis; Other: laboratory biomarker analysis
Sponsors: Case Comprehensive Cancer Center; The Cleveland Clinic; Ireland Cancer Center
Recruiting - verified March 2010
Condition: Acromegaly
Interventions: Drug: Octreotide acetate LAR; Drug: Sandostatin LAR ® (octreotide acetate LAR) 30 MG
Sponsor: L.A.L Clinica Pesquisa e Desenvolvimento Ltda.
Not yet recruiting - verified March 2010
Condition: Adult Growth Hormone Deficiency
Intervention:
Sponsor: Merck KGaA
Active, not recruiting - verified March 2010
Condition: Contraception
Interventions: Drug: Desogestrel-Ethinyl Estradiol contraceptive pill; Drug: Etonogestrel-Ethinyl Estradiol vaginal ring; Drug: Norelgestromin-Ethinyl Estradiol contraceptive patch
Sponsor: University of Oulu
Recruiting - verified March 2010
Condition: Pancreatic Disease
Interventions: Drug: ChiRhoStim; Drug: Placebo
Sponsor: ChiRhoClin, Inc.
Completed - verified March 2010
Condition: Fibromyalgia
Intervention: Drug: 17β-estradiol
Sponsor: Ostergotland County Council, Sweden
Terminated - verified September 2001
Conditions: Obesity; Bariatric Surgery; Morbid Obesity; Diabetes Mellitus Type 2; Diet Therapy
Interventions: Procedure: Roux-en-Y Gastric Bypass; Behavioral: Caloric Restriction
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: Ovulation Induction
Intervention: Drug: Recombinant FSH (follitropin alpha)
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Breast Cancer
Interventions: Drug: XL147; Drug: XL765; Drug: letrozole (Femara)
Sponsor: Exelixis
Not yet recruiting - verified March 2010
Conditions: Physiology; Gastroenterology; Endocrinology
Intervention: Other: Glucose-insulinotropic peptide, Glucagon-like peptide-1
Sponsors: Uppsala University; Karolinska Institutet; University of Copenhagen
Completed - verified July 2009
Condition: Multifollicular Stimulation
Intervention: Drug: Recombinant-follicle stimulating hormone (r-FSH)
Sponsor: Merck KGaA
Active, not recruiting - verified March 2010
Conditions: Type 2 Diabetes; Morbid Obesity
Intervention:
Sponsor: University Hospital, Gasthuisberg
Recruiting - verified March 2010
Condition: Crohn´s Disease
Interventions: Drug: budesonide; Drug: budesonide
Sponsor: Dr. Falk Pharma GmbH
Recruiting - verified March 2010
Condition: Asthma
Intervention: Drug: 10 mg tablet of montelukast (Singulair)
Sponsors: Nemours Children's Clinic; Merck Investigator Initiated Studies Program
Recruiting - verified March 2010
Condition: Atrophic Vaginitis
Interventions: Drug: intravaginal estradiol; Drug: intravaginal estradiol
Sponsor: Novo Nordisk
Not yet recruiting - verified March 2010
Condition: Asthma
Interventions: Drug: Placebo Inhalation Powder; Drug: Placebo Oral Capsule; Drug: Fluticasone Furoate/GW642444 Inhalation Powder; Drug: Prednisolone Oral Capsule; Drug: Fluticasone Furoate/GW642444 Inhalation Powder
Sponsor: GlaxoSmithKline
Not yet recruiting - verified March 2010
Conditions: Infertility; Ovulation Induction
Interventions: Drug: Lutropin alfa for injection (r-hLH) + r-hFSH; Drug: r-hFSH preparation
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Hormone Withdrawal Associated Symptoms
Interventions: Drug: EE20/DRSP (YAZ, BAY86-5300); Drug: Ethinylestradiol (EE) and desogestrel (DSG) (Mercilon)
Sponsor: Bayer
Not yet recruiting - verified February 2010
Condition: Prostate Cancer
Interventions: Drug: TAK-700; Drug: Docetaxel; Drug: Prednisone
Sponsor: Millennium Pharmaceuticals, Inc.
Recruiting - verified March 2010
Conditions: Type 2 Diabetes; Hypogonadism
Intervention: Drug: Testosterone
Sponsor: Tameside Hospital NHS Foundation Trust
Not yet recruiting - verified November 2008
Condition: Prostate Cancer
Intervention: Dietary Supplement: Olive Oil
Sponsors: Brown University; The Miriam Hospital
Recruiting - verified October 2009
Condition: Healthy
Interventions: Drug: Spironolactone; Drug: Spironolactone; Drug: Spironolactone
Sponsor: Orion Corporation, Orion Pharma
Not yet recruiting - verified March 2010
Condition: Contraception
Interventions: Drug: Gestodene/EE Patch (BAY86-5016); Drug: Gestodene/EE Patch (BAY86-5016); Drug: Gestodene/EE Patch (BAY86-5016)
Sponsor: Bayer
Recruiting - verified March 2010
Conditions: Relapsed and Bortezomib Refractory Multiple Myeloma; Refractory Multiple Myeloma; Relapsed Multiple Myeloma
Intervention: Drug: panobinostat, bortezomib, dexamethasone
Sponsor: Novartis
Not yet recruiting - verified March 2010
Condition: Infertility
Interventions: Drug: r-hCG; Drug: Urinary-hCG
Sponsor: Merck KGaA
Completed - verified March 2010
Condition: Hormone Replacement Therapy, Post-Menopausal
Intervention: Drug: 0.5 mg estradiol and 0.1mg norethisterone acetate
Sponsor: Novo Nordisk
Not yet recruiting - verified February 2010
Condition: Multiple Myeloma
Intervention: Drug: velcade
Sponsor: PETHEMA Foundation
Not yet recruiting - verified March 2010
Condition: Oral Lichen Planus
Interventions: Drug: Minocycline; Drug: Dexamethasone
Sponsor: Sheba Medical Center
Not yet recruiting - verified March 2010
Condition: Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome
Intervention: Biological: Serostim
Sponsor: EMD Serono
Completed - verified March 2010
Conditions: Advanced Prostate Cancer; Lower Urinary Tract Symptoms
Intervention: Drug: Leuprolide acetate Depot Susp. 11,25 mg (Poland), 3,75 mg (Ukraine)
Sponsors: Abbott; Fraktal; TFS Trial Form Support
Active, not recruiting - verified February 2010
Condition: Small Bowel Obstruction
Interventions: Drug: Somatostatin; Other: common daily practice
Sponsor: Nanjing PLA General Hospital
Not yet recruiting - verified February 2010
Conditions: Castrate-Resistant Prostate Cancer; Hormone Refractory Prostate Cancer
Interventions: Drug: custirsen sodium; Drug: Isotonic, 0.9% sodium chloride
Sponsors: OncoGenex Technologies; Teva Pharmaceuticals USA
Not yet recruiting - verified March 2010
Condition: Polycystic Ovary Syndrome
Intervention: Behavioral: Nutrition Education, Dietary Counseling, and Cooking
Sponsors: Children's Hospital Boston; Thrasher Research Fund
Not yet recruiting - verified March 2010
Condition: Infertility
Interventions: Drug: Micronised Progesterone; Drug: Progesterone
Sponsor: Merck KGaA
Completed - verified March 2010
Condition: PROSTATE CANCER.
Interventions: Drug: Docetaxel and Prednisone; Drug: Docetaxel and Prednisone; Drug: Radiation Therapy
Sponsors: Northwestern University; Genzyme
Not yet recruiting - verified March 2010
Condition: Prostate Cancer
Interventions: Drug: Neoadjuvant Hormonal Therapy; Drug: Docetaxel
Sponsor: M.D. Anderson Cancer Center
Active, not recruiting - verified February 2010
Condition: Relapsed Multiple Myeloma
Interventions: Drug: Dexamethasone; Drug: Lenalidomide; Drug: Carfilzomib
Sponsor: Onyx Therapeutics, Inc.
Not yet recruiting - verified March 2010
Condition: Acute Gout
Interventions: Drug: ACZ885; Drug: Triamcinolone acetonide
Sponsor: Novartis Pharmaceuticals
Recruiting - verified March 2010
Condition: Reproductive Techniques, Assisted
Interventions: Drug: r-hFSH and r-hLH; Drug: r-hFSH
Sponsor: Merck KGaA
Terminated - verified July 2004
Condition: Endometrial Cancer
Intervention:
Sponsors: Queensland Centre for Gynaecological Cancer; Greenslopes Private Hospital; University of Queensland; Sullivan and Nicolaides Pathology
Recruiting - verified February 2010
Condition: Waldenstrom's Macroglobulinemia
Interventions: Drug: pomalidomide; Drug: dexamethasone; Drug: rituximab
Sponsors: Dana-Farber Cancer Institute; Celgene Corporation
Not yet recruiting - verified March 2010
Condition: Obesity
Intervention:
Sponsor: Meir Medical Center
Not yet recruiting - verified February 2010
Condition: Multifollicular Stimulation
Intervention: Drug: Gonal-F (Follitropin alfa)
Sponsor: Merck KGaA
Recruiting - verified February 2010
Condition: Prostate Cancer
Interventions: Drug: HDAC inhibitor SB939; Other: laboratory biomarker analysis
Sponsor: NCIC Clinical Trials Group
Recruiting - verified February 2010
Condition: Hormone Replacement Therapy
Interventions: Drug: Estradiol acetate; Drug: Estradiol; Drug: Conjugated equine estrogens
Sponsor: Warner Chilcott
Completed - verified February 2010
Conditions: Infertility; Ovulation Induction
Intervention: Drug: Lutropin alfa
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: bortezomib; Drug: cyclophosphamide; Drug: dexamethasone; Drug: pegylated liposomal doxorubicin hydrochloride
Sponsors: Eastern Cooperative Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified March 2010
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: bortezomib; Drug: dexamethasone; Drug: melphalan
Sponsors: Eastern Cooperative Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified February 2010
Conditions: Infertility; Ovulation Induction
Interventions: Drug: Follitropin alfa liquid formulation; Drug: Follitropin beta liquid formulation
Sponsor: Merck KGaA
Completed - verified March 2010
Conditions: Secondary Hyperparathyroidism; Chronic Kidney Disease
Intervention: Drug: paricalcitol iv (Zemplar iv)
Sponsor: Abbott
Active, not recruiting - verified March 2010
Conditions: Growth Disorders; Intrauterine Growth Retardation
Interventions: Drug: Genotonorm; Drug: Genotonorm; Drug: Genotonorm
Sponsor: Pfizer
Completed - verified February 2010
Conditions: Metabolic Syndrome; Hypercholesterolemia
Intervention: Drug: Metformin
Sponsor: Sydney West Area Health Service
Recruiting - verified February 2010
Condition: Breast Cancer
Interventions: Drug: ZD9393 (Zoladex); Drug: ZD9393 (Zoladex)
Sponsor: AstraZeneca
Not yet recruiting - verified February 2010
Condition: Breast Cancer
Intervention:
Sponsor: Korean Breast Cancer Study Group
Recruiting - verified February 2010
Condition: Breast Cancer
Intervention:
Sponsor: Park Nicollet Institute
Recruiting - verified February 2010
Condition: Breast Cancer
Intervention: Drug: Letrozole
Sponsor: Korean Breast Cancer Study Group
Enrolling by invitation - verified February 2010
Conditions: Breast Cancer; CYP2D6 Polymorphism
Intervention: Drug: Tamoxifen
Sponsor: Sydney West Area Health Service
Not yet recruiting - verified February 2010
Condition: Arthritis, Rheumatoid
Intervention: Drug: Prednisone
Sponsor: Merck KGaA
Recruiting - verified February 2010
Conditions: Breast Cancer; Bone Metastases
Intervention: Drug: Radium-223 chloride (Alpharadin)
Sponsor: Algeta ASA
Recruiting - verified March 2010
Conditions: Secondary Hyperparathyroidism; Chronic Kidney Disease Stage V; Cardiac Morbidity
Intervention:
Sponsors: Abbott; Assign Group Data Management Biostatistics
Recruiting - verified February 2010
Conditions: Nausea; Vomiting; Genital Neoplasms, Female
Intervention: Drug: Fosaprepitant dimeglumine
Sponsors: Odense University Hospital; Helsinn Healthcare SA
Not yet recruiting - verified December 2009
Condition: Endometrial Hyperplasia
Interventions: Drug: Provera (medroxyprogesterone/progestin); Drug: Provera (medroxyprogesterone); Device: Mirena (levonorgestrel)
Sponsors: University Hospital of North Norway; Helse Nord; Norwegian Cancer Society
Recruiting - verified February 2010
Condition: Hemangioma
Interventions: Drug: Prednisolone (Corticosteroid); Drug: Propanolol; Drug: Placebo
Sponsor: Seattle Children's Hospital
Not yet recruiting - verified February 2010
Condition: Radiculopathy
Intervention: Drug: Kenalog and Sensorcaine
Sponsor: Saint John Regional Hospital
Not yet recruiting - verified January 2010
Condition: Physical and Psychological Evaluation of Hormonal Therapy in Transsexual Persons
Interventions: Other: questionnaires; Biological: blood sampling; Other: clinical evaluation; Other: Dermatology evaluation; Other: Bone evaluation
Sponsor: University Hospital, Ghent
Recruiting - verified February 2010
Condition: Prostate Cancer
Intervention: Drug: Degarelix
Sponsors: Ferring Pharmaceuticals; Ferring Pharmaceuticals Korea, Ltd.
Not yet recruiting - verified February 2010
Condition: Enteritis
Intervention: Drug: DOR201 (delayed release beclomethasone dipropionate)
Sponsors: Soligenix; National Cancer Institute (NCI)
Recruiting - verified February 2010
Condition: Acute Gout
Interventions: Drug: ACZ885; Drug: Triamcinolone acetonide
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - verified February 2010
Condition: Hemangioma
Interventions: Drug: Propranolol; Drug: Prednisone
Sponsors: University of Sao Paulo; University of Sao Paulo General Hospital
Recruiting - verified December 2009
Condition: Polycystic Ovary Syndrome
Interventions: Drug: Atorvastatin; Drug: Placebo
Sponsors: University of Oulu; Pfizer
Recruiting - verified February 2010
Condition: Asthma
Interventions: Drug: CHF 5188 pMDI; Drug: Budesonide extrafine pMDI; Drug: Seretide(r) Evohaler(r)
Sponsor: Chiesi Farmaceutici S.p.A.
Recruiting - verified February 2010
Condition: Exercise Induced Asthma
Interventions: Drug: Budesonide/Formoterol; Drug: Budesonide
Sponsors: Children's Hospital Boston; Brigham and Women's Hospital
Recruiting - verified February 2010
Condition: Multiple Myeloma de Novo Treatment
Interventions: Drug: Thalidomide, Dexamethasone; Drug: Vincristin , Adriamycin, Dexamethasone = VAD; Drug: Thalidomide, melphalan, endoxan, dexamethasone (MCDex-Thal); Drug: melphalan, endoxan, dexamethasone (MCDex); Drug: Thalidomide, Dexamethasone
Sponsors: University Hospital, Caen; Laphal
Completed - verified February 2010
Condition: Primary Systemic Amyloidosis
Interventions: Drug: bortezomib; Drug: cyclophosphamide; Drug: dexamethasone
Sponsor: Mayo Clinic
Not yet recruiting - verified February 2010
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: natalizumab; Drug: interferon beta 1-a; Drug: methylprednisolone; Other: IV placebo; Drug: glatiramer acetate
Sponsors: Biogen Idec; Elan Pharmaceuticals
Not yet recruiting - verified February 2010
Condition: Congenital Hyperinsulinism
Intervention: Drug: Lanreotide autogel
Sponsor: Sheba Medical Center
Not yet recruiting - verified February 2010
Conditions: Congenital Heart Disease; Heart Failure; Endomyocardial Fibrosis
Interventions: Drug: Spironolactone; Other: Placebo
Sponsors: Oregon Health and Science University; National Heart, Lung, and Blood Institute (NHLBI); Oregon Clinical and Translational Research Institute
Not yet recruiting - verified January 2010
Condition: Polycystic Ovarian Syndrome
Interventions: Drug: Endometrin (progesterone 100mg vaginal inserts); Drug: Metformin
Sponsors: Yale University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2010
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
